407 related articles for article (PubMed ID: 16203039)
1. Epidemiology and clinical outcome of enterococcal bacteraemia in an acute care hospital.
Poh CH; Oh HM; Tan AL
J Infect; 2006 May; 52(5):383-6. PubMed ID: 16203039
[TBL] [Abstract][Full Text] [Related]
2. Enterococcal bacteremia in a teaching hospital in the Central region of Saudi Arabia.
Al-Otaibi FE; Kambal AM; Baabbad RA
Saudi Med J; 2004 Jan; 25(1):21-5. PubMed ID: 14758373
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
Mave V; Garcia-Diaz J; Islam T; Hasbun R
J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543
[TBL] [Abstract][Full Text] [Related]
5. Enterococcal bacteraemia in a tertiary care hospital of North India.
Mohanty S; Kapil A; Das BK
J Indian Med Assoc; 2005 Jan; 103(1):31-2, 34, 36-7. PubMed ID: 16008327
[TBL] [Abstract][Full Text] [Related]
6. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607
[TBL] [Abstract][Full Text] [Related]
7. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies.
Todeschini G; Tecchio C; Borghero C; D'Emilio A; Pegoraro E; de Lalla F; Benedetti P; Spolaore P; Pellizzer G
J Infect; 2006 Oct; 53(4):266-73. PubMed ID: 16388852
[TBL] [Abstract][Full Text] [Related]
8. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
Marron A; Carratalà J; Ayats J; Fernández de Sevilla A; Domínguez MA; Liñares J; Gudiol F
Med Clin (Barc); 1998 Dec; 111(20):761-4. PubMed ID: 9922964
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and outcomes of surgical patients with vancomycin-resistant enterococcal infections.
Joels CS; Matthews BD; Sigmon LB; Hasan R; Lohr CE; Kercher KW; Norton J; Sing RF; Heniford BT
Am Surg; 2003 Jun; 69(6):514-9. PubMed ID: 12852510
[TBL] [Abstract][Full Text] [Related]
10. [Enterococcal endocarditis: a multicenter study of 76 cases].
Martínez-Marcos FJ; Lomas-Cabezas JM; Hidalgo-Tenorio C; de la Torre-Lima J; Plata-Ciézar A; Reguera-Iglesias JM; Ruiz-Morales J; Márquez-Solero M; Gálvez-Acebal J; de Alarcón-González A;
Enferm Infecc Microbiol Clin; 2009 Dec; 27(10):571-9. PubMed ID: 19477041
[TBL] [Abstract][Full Text] [Related]
11. Enterococcal meningitis: a clinical study of 39 cases and review of the literature.
Pintado V; Cabellos C; Moreno S; Meseguer MA; Ayats J; Viladrich PF
Medicine (Baltimore); 2003 Sep; 82(5):346-64. PubMed ID: 14530784
[TBL] [Abstract][Full Text] [Related]
12. Enterococcal bacteraemia: epidemiological, microbiological, clinical and prognostic characteristics, and the impact of high level gentamicin resistance.
Shaked H; Carmeli Y; Schwartz D; Siegman-Igra Y
Scand J Infect Dis; 2006; 38(11-12):995-1000. PubMed ID: 17148067
[TBL] [Abstract][Full Text] [Related]
13. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
Mohr JF; Friedrich LV; Yankelev S; Lamp KC
Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
[TBL] [Abstract][Full Text] [Related]
14. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients.
Gallagher JC; Perez ME; Marino EA; LoCastro LG; Abrardo LA; MacDougall C
Pharmacotherapy; 2009 Jul; 29(7):792-9. PubMed ID: 19558253
[TBL] [Abstract][Full Text] [Related]
15. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC
J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor?
Chen SC; Lawrence RH; Byth K; Sorrell TC
Med J Aust; 1993 Nov; 159(9):592-7. PubMed ID: 8232033
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study.
Anderson DJ; Murdoch DR; Sexton DJ; Reller LB; Stout JE; Cabell CH; Corey GR
Infection; 2004 Apr; 32(2):72-7. PubMed ID: 15057570
[TBL] [Abstract][Full Text] [Related]
18. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: a population-based cohort study.
Pinholt M; Ostergaard C; Arpi M; Bruun NE; Schønheyder HC; Gradel KO; Søgaard M; Knudsen JD;
Clin Microbiol Infect; 2014 Feb; 20(2):145-51. PubMed ID: 23647880
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
King EA; McCoy D; Desai S; Nyirenda T; Bicking K
J Antimicrob Chemother; 2011 Sep; 66(9):2112-8. PubMed ID: 21697178
[TBL] [Abstract][Full Text] [Related]
20. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation.
Kapur D; Dorsky D; Feingold JM; Bona RD; Edwards RL; Aslanzadeh J; Tutschka PJ; Bilgrami S
Bone Marrow Transplant; 2000 Jan; 25(2):147-52. PubMed ID: 10673672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]